Vittamed is a commercial stage neurodiagnostic company based in the Boston area with research and manufacturing operations in Lithuania. Vittamed has developed a platform of innovative noninvasive devices: Vittamed 205 non-invasive intracranial pressure (ICP) system that does not require patient specific calibration; and Vittamed 505 non-invasive bedside monitor for assessing cerebrovascular autoregulation. Both devices have CE Mark approval.